Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of inflammatory arthritis

Table 1 Patient characteristics

Age (years)	37 (29–60)
Gender (female)	8
Diagnosis
Rheumatoid arthritis	8
Peripheral spondyloarthritis	6
Disease duration (years)	6.5 (1.5–19)
Treatment
Methotrexate	6
Sulfasalazine	3
TNF inhibitor	3
Disease activity
CRP (mg/L)	20.0 (6.5–55.0)
DAS28CRP (0–10)	3.56 (3.1–4.5)

Data are expressed as median (interquartile range). Information on disease duration, treatment, and disease activity was missing in 4 patients. TNF; tumor necrosis factor; C-reactive protein; DAS28CRP, Disease activity score based on CRP and number of tender and swollen joints in 28 joints

ISSN: 1471-2172